Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)

NCT06235281 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

SUSPENDED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Slow Accrual

Conditions

Mycosis Fungoides

Interventions

DRUG: Mogamulizumab-Kpkc
DEVICE: Phototherapy

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]